Spotlight Innovation, Inc. Stock Price - STLT

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Spotlight Innovation Inc. (QB) STLT OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 0.007275 0.00 0.00 0.00 0.007275 15:59:42
Bid Price Ask Price Spread Spread % News
0.0057 0.0125 0.0068 54.4% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Spotlight Innovation, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 260.17k 35.76M $ -6.17M - - 9.63M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
3.19k $ - 0.00% - -

more financials information »

Spotlight Innovation, Inc. News

Loading Messages....

Latest STLT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical STLT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00570.008850.00570.00763721,4350.0015827.63%
1 Month0.0060.008850.00570.005777510,4180.0012821.25%
3 Months0.010980.0150.00570.010263610,447-0.00371-33.74%
6 Months0.0150.0340.00570.010451210,081-0.00773-51.5%
1 Year0.0260.0340.0020.010799413,060-0.01873-72.02%
3 Years0.700.800.0020.295988735,249-0.69273-98.96%
5 Years1.651.800.0020.368996926,278-1.64-99.56%

Spotlight Innovation, Inc. Description

Spotlight Innovation Inc. (OTCQB: STLT) acquires and develops proprietary therapies to address unmet medical needs, with an emphasis on rare, emerging and neglected diseases. The Company identifies in-licensing opportunities and manages product development through partnerships with universities, medical schools, contract research organizations (CROs), and contract manufacturing organizations (CMOs). At the appropriate stage of research and development the Company will endeavor to pursue product commercialization opportunities including, but not limited to, out-licensing and strategic partnerships with industry leaders.


Your Recent History
USOTC
STLT
Spotlight ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.